DESCRIPTION DU PRODUIT
Description capsules PEA NATUREL Palmitoyléthanolamide
PEA NATUREL Palmitoyléthanolamide est un complément alimentaire basé sur une liaison naturelle d’acides gras.
La palmitoyléthanolamide (PEA) est une molécule présente dans le corps agissant sur le plan physiologique.
Ce que le consommateur doit savoir avant la prise
Dosage et administration
Les premiers mois: 1 capsule 3 fois par jour
Les 2 mois suivants: en cas de résultat, 1 capsule 2 fois par jour
A partir de 4 mois: vous pouvez envisager de:
- Continuer la prise de 1 capsule 2 fois par jour
- Diminuer la prise à 1 capsule 1 fois par jour
- Arrêter la prise
En cas de rechute, il est recommandé d’augmenter à nouveau la prise de 1 capsule 2 ou 3 fois par jour.
En cas de dosage correcte, PEA Palmitoyléthanolamide PUR peut être administré de manière permanente.
Dosage quotidien |
| ADH % |
Palmitoylethanolamide | 1200 mg | ------ |
Avertissements
* Les compléments alimentaires ne doivent pas être utilisés en remplacement d’une alimentation variée.
* Conservez ce complément alimentaire au sec, à température ambiante et hors de portée des jeunes enfants.
Contenu et ingrédients
90 capsules végétales
Chaque capsule contient 400 mg de: PalmitoylEthanolAmide (PEA)
Ingrédients: palmitoyléthanolamide, hydroxypropylméthylcellulose (capsule).
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
NO DELIVERY IN BELGIUM !!!!!!!
Useful for all kinds of chronic pain - 90 vegetarian capsules - dose for 1 month (3 capsules a day)
Description of PEA NATUREL - Palmitoylethanolamide 400 mg capsules
PEA NATUREL Palmitoylethanolamide is a food supplement based on a natural and fatty-acid like compound.
The substance palmitoylethanolamide (PEA) is a physiologically active molecule that the body produces naturally.
.
What the user should know prior to ingestion:
*There are no known significant side effects.
*PEA NATUREL Palmitoylethanolamide can
be taken simultaneously with other medicine. In case of doubt, it is
recommended to first consult your doctor or a pharmacist.
*Use during pregnancy is NOT recommended.
*PEA NATUREL Palmitoylethanolamide does not contain sugar, yeast, allergens, sorbitol, magnesium stearate, povidone or other ingredients.
Dosage and administration
Administration: During or after the meal, swallow 1 capsule together with water, or sprinkle the content of the capsule on your food.
Dosage:
First 2 months: 3 times 1 capsule daily
Next 2 months: In case of a positive result, 2 times 1 capsule daily
After 4 months, you can consider the following:
• Continue taking 2 times 1 capsule daily.
• Reduce the ingestion to 1 time 1 capsule daily.
• Stop the ingestion.
In case of regression, it is recommended to increase the dosage to 2 or 3 times 1 capsule daily.
It is possible to continue taking PEA NATUREL Palmitoylethanolamide in the correct dosage.
Do not exceed the recommended daily dosage.
Dose recommendations of PEA NATUREL
Dose recommendation: start with 1200 mg daily in 2 to 3 doses (e.g. 2 capsules after breakfast and 1 capsule after diner). In case of severe pain, migraine or for special indications such as Lou Gehrings disease it is recommended to open the capsule and put the PEA under the tongue for longer periodes of time. The PEA dissolves in the mouth and is absorbed via the oral mucosa to enter directly into the body, not being partly digested in the gut. This gives a jumpstart which might be desirable, but is not always necessary.
PEA is the body’s own modulator, and not a painkiller such as NSAIDs and morphine. It does mostly need some weeks to slowly bring the body in balance on a number of biological levels. As PEA has a number of modulating effects, both on the short term as well as slowly increasing, there are patients experiencing quick pain relief within some days. There are also patients who need more time (especially in chronic pain situations). Therefore the recommendation is to test the efficacy of PEA during two months in cases of chronic pain before deciding on its efficacy.
If pain decreases more than 30% one can reduce the dose of PEA NATUREL
to 2 times 400 mg. If pain increases under PeaPure treatment, as some
chronic pain syndromes sometimes waxes and wanes (given the weather,
given excercise, food, etc) it is recommended to increase the dose to
800 mg twice daily..
Warnings
• It is not allowed to use food supplements as replacement for a varied diet.
• Keep this food supplement dry and at room temperature. Keep out of reach of small children..
Content and ingredients
90 vegetarian capsules
Each capsule contains 400 mg palmitoylethanolamide (PEA).
Ingredients: palmitoylethanolamide, hydroxypropylmethylcellulose (capsule)
Therapists newsletter
Palmitoylethanolamide
(PEA) is hot. Since 2005, PEA has been of scientific interest.
Recently, several scientific arguments were published that clearly
indicate that PEA in 100% pure form -
as is used in PEA NATUREL Palmitoylethanolamide - is the most proper form for using PEA.
We quote one of the authors:’ …the preference should be for the time being to treat patients with pure PEA without any of these additives’. (1)
Treatment
of various disorders that are characterised by chronic pains or
infections with natural PEA has been extensively discussed in two recent
Dutch publications that appeared in the magazines PlaceboNocebo (2) and
Physician, Therapist and Pharmacist (Dutch: Arts, Therapeut en
Apotheker).(3)
The former article includes a table that provides an
overview of the physiological effects of PEA; this table is provided
below. The table summarises many of the characteristics of PEA and has
been created based on the most recent study results. The harmonising
effect of PEA is striking, which is the result of various points of
action:
Characteristics of PEA
This
year, several Dutch physicians jointly published an article with an
American pain specialist about the value of PEA in unexplainable vaginal
pains, a common disorder with only few treatments. (4) Furthermore, it
has become more and more clear that PEA protects many cells, such as
nerve cells, against harmful irritations. (5) PEA exerts this protective
mechanism by calming down overactive inflammatory genes in the cell
nucleus. As early as in the 1980s, it was discovered that cells that are
threatened produce PEA to protect themselves. Recently, this
self-regulating protective mechanism has once again become clear. For
example in eczema, a chronic infection, the skin produces more PEA in
order to contain the infection. (6)
In this way, PEA continues
to be of great interest and fortunately there are increasingly more
therapists and physicians who are aware of the characteristics of this
fascinating natural substance. Especially the fact that PEA is easy to
combine with any other medication or supplement is a great advantage to
its users.
References:
1. Kriek R.
Palmitoylethanolamide: problems regarding micronization,
ultra-micronization and additives. Inflammopharmacology. 2014 Mar 20.
2.
Hilda Maris, Jan M. Keppel Hesselink. Palmitoylethanolamide (PEA): een
natuurlijke pijnstiller en veel meer. PlaceboNocebo, wetenschap,
voeding, bewustzijn, harmonie: 2013, jaargang 3, nummer 13:36-38
3.
Stichting Orthokennis. Palmitoylethanolamide, effectieve lichaamseigen
pijnstiller en ontstekingsremmer. Arts, therapeut en apotheker, 2014:
jaargang 15, nr 2: 54-58
4. Keppel Hesselink JM, Kopsky DJ,
Sajben NL. Vulvodynia and proctodynia treated with topical baclofen 5 %
and palmitoylethanolamide. Arch Gynecol Obstet. 2014 Apr 2.
5.
Fidaleo M, Fanelli F, Ceru MP, Moreno S. Neuroprotective Properties of
Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid
Ligands. Curr Med Chem. 2014 Mar 3.
6. Abramo F, Campora L,
Albanese F, della Valle MF, Cristino L, Petrosino S, Di Marzo V,
Miragliotta V. Increased levels of palmitoylethanolamide and other
bioactive lipid mediators and enhanced local mast cell proliferation in
canine atopic dermatitis.
BMC Vet Res. 2014 Jan 14;10:21. doi: 10.1186/1746-6148-10-21.